Lawrence J. Wilson,John Wiseman,Dennis C. Liotta,Michael G. Natchus
申请号:
US14623772
公开号:
US09545403B2
申请日:
2015.02.17
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for managing CXCR4 related conditions, typically prevention or treatment of viral infections such as HIV or for managing cancer.